Haemonetics 2nd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website

Rhea-AI Summary

Haemonetics Corporation (NYSE:HAE) has released its financial results for the second quarter of fiscal 2021, concluding on September 26, 2020. The earnings release and results tables are accessible on its Investor Relations website, along with a scheduled conference call for investors on November 4, 2020, at 8 a.m. EST. Key financial metrics and strategic updates are expected to be discussed during this call. Investors can also view the live webcast for detailed insights into the company's performance.

BOSTON, Nov. 4, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its second quarter fiscal 2021, which ended September 26, 2020, are available on its Investor Relations website.

In addition, the Company is also posting the earnings release and results tables that will be referenced on its webcast.  

Direct link to Earnings Release 2Q FY 21:
https://haemonetics.gcs-web.com/static-files/d1a82d47-6697-4dab-ab92-d752fb87aa36

Direct link to Results Tables 2Q FY 21 for reference on webcast conference call: https://haemonetics.gcs-web.com/static-files/69c24b35-7dfa-4bbb-a0fd-db0a52045192

The Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8 a.m. EST November 4, 2020. The call can be accessed with the following information:

• U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
• Conference ID required for access: 3899118
• A live webcast of the call can be accessed on Haemonetics' Investor Relations website.
• Direct link to conference call webcast: https://edge.media-server.com/mmc/p/ge7vnpw8

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our website at http://www.haemonetics.com. 

Investor Contact	Media Contact
Olga Guyette, Director-Investor Relations	Carla Burigatto, VP-Communications
(781) 356-9763	(781) 348-7263
olga.guyette@haemonetics.com	carla.burigatto@haemonetics.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2021-earnings-release-available-on-investor-relations-website-301166087.html

SOURCE Haemonetics Corporation

FAQ

What are the financial results for Haemonetics in Q2 FY 2021?

Haemonetics has released its financial results for Q2 FY 2021, available on their Investor Relations website.

When will Haemonetics hold its conference call to discuss earnings?

Haemonetics will host a conference call for investors on November 4, 2020, at 8 a.m. EST.

How can I access the earnings release for Haemonetics?

The earnings release for Haemonetics can be accessed directly via their Investor Relations website.

What is the significance of the Q2 FY 2021 results for Haemonetics?

The Q2 FY 2021 results are significant as they provide insights into the company's financial performance and strategic direction.